home / stock / wba / wba articles
Consulting firm McKinsey & Company has reached a substantial settlement agreement of $230 million to resolve lawsuits filed by numero...
Walgreens Boots Alliance Inc (NASDAQ: WBA) is in hot water as it grapples with a proposed class action lawsuit in Florida federal court allegi...
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have hig...
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several l...
The FDA has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products violating federa...
Tech Crunch Jeff Bezos Vs. Elon Musk: Feud Takes Center Stage in Amazon's Space Contract Lawsuit An institutional investor prosecuted Ama...
Walgreens Boots Alliance Inc's (NASDAQ: WBA) CEO has agreed to step down as CEO and board member as of August 31, 2023. The company ...
Walgreens Boots Alliance Inc (NASDAQ: WBA) said over-the-counter (OTC) NARCAN Nasal Spray will be available at Walgreens stores and ...
News, Short Squeeze, Breakout and More Instantly...
Walgreens Boots Alliance Inc. Company Name:
WBA Stock Symbol:
NASDAQ Market:
Walgreens Boots Alliance Inc. Website:
This study aims to enhance U.S. public health preparedness through Walgreens community pharmacy network, improving access and diversity in clinical trials via a $25m award Walgreens today announced it received a project award valued up to $25 million through the Rapid Response Partnersh...
2024-07-18 13:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-17 06:35:00 ET Walgreens Boots Alliance (NASDAQ: WBA) is a stock that is in deep trouble. It isn't trading just at 52-week lows, it's trading at levels it hasn't seen in more than 20-plus years. The company's new CEO, Tim Wentworth, faces an uphill battle trying to turn thin...